Outset Medical, Inc. (OM) Operating Margin
- Operating margin · 12 months: Value -56.06%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -56.06% | Operating income / revenue. Period ending 2026-06-30. $-66.04M ÷ $117.80M × 100 ≈ -56.06% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -66.04M USD | Operating Income (Loss) |
| Revenue | 117.80M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 68.61M USD | Cost of Goods and Services Sold |
| Research and development | 21.50M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-66.04M | $117.80M | $68.61M | $21.50M | (m) | -56.06% |
| 2026-03-31 | $-67.23M | $117.59M | $69.80M | $21.34M | (m) | -57.17% |
| 2025-12-31 | $-66.71M | $119.48M | $72.72M | $21.23M | (m) | -55.83% |
| 2025-09-30 | $-70.94M | $120.07M | $74.80M | $24.07M | (m) | -59.08% |
| 2025-06-30 | $-78.96M | $119.30M | $75.80M | $26.83M | (m) | -66.19% |
| 2025-03-31 | $-92.86M | $115.27M | $73.86M | $31.28M | (m) | -80.56% |
| 2024-12-31 | $-113.38M | $113.69M | $75.13M | $38.40M | (m) | -99.72% |
| 2024-09-30 | $-128.87M | $114.73M | $79.20M | $43.04M | (m) | -112.32% |
| 2024-06-30 | $-150.48M | $116.42M | $83.56M | $50.98M | (m) | -129.25% |
| 2024-03-31 | $-163.20M | $125.08M | $94.29M | $56.15M | (m) | -130.48% |
| 2023-12-31 | $-169.77M | $130.38M | $101.38M | $57.31M | (m) | -130.22% |
| 2023-09-30 | $-172.24M | $131.88M | $105.31M | $56.22M | (m) | -130.61% |
| 2023-06-30 | $-167.79M | $129.28M | $105.53M | $53.20M | (m) | -129.79% |
| 2023-03-31 | $-168.03M | $118.29M | $98.47M | $51.82M | (m) | -142.05% |
| 2022-12-31 | $-161.02M | $115.38M | $97.54M | $48.85M | (m) | -139.56% |
| 2022-09-30 | $-161.99M | $111.52M | $95.64M | $48.82M | (m) | -145.26% |
| 2022-06-30 | $-151.13M | $110.08M | $95.59M | $45.49M | (m) | -137.30% |
| 2022-03-31 | $-137.32M | $110.24M | $98.47M | $40.00M | (m) | -124.57% |
| 2021-12-31 | $-130.52M | $102.60M | $94.99M | $36.74M | (m) | -127.21% |
| 2021-09-30 | $-121.33M | $91.70M | $86.99M | $33.12M | (m) | -132.32% |
| 2021-06-30 | $-131.93M | $79.14M | $82.50M | $32.56M | (m) | -166.72% |
| 2021-03-31 | $-126.93M | $65.66M | $74.84M | $30.58M | (m) | -193.32% |
| 2020-12-31 | $-117.47M | $49.94M | $62.97M | $28.85M | (m) | -235.24% |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $28.65M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $19.78M | (m) | (m) | (m) | (m) |
| 2019-12-31 | $-70.31M | $15.08M | $32.88M | $23.33M | (m) | -466.29% |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $-46.56M | $2.01M | $8.12M | $22.92M | (m) | -2320.03% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |